Your session is about to expire
← Back to Search
Smoking Cessation App for Smokers
N/A
Waitlist Available
Led By Paul Cinciripini
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 weeks
Awards & highlights
Study Summary
This trial looks at whether a mobile app can help people quit smoking. The app is based on a computer program that has helped people quit smoking in the past.
Who is the study for?
This trial is for adult smokers who smoke at least 5 cigarettes daily, have a carbon monoxide level of 7 ppm or higher, and are willing to quit within 5 weeks. Participants must own an iPhone or Android smartphone and be enrolled in the Tobacco Treatment Program at MD Anderson Cancer Center.Check my eligibility
What is being tested?
The trial is testing 'Quitting Schedule,' a mobile app designed to help people stop smoking. It's based on WebCASSI, which provided cessation treatment and counseling. The study will see if this app can effectively assist participants in quitting smoking.See study design
What are the potential side effects?
Since this intervention involves using a smartphone application for smoking cessation support, there are no direct medical side effects like those associated with drugs or medical procedures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adaptation of the programmatic infrastructure of WebCASSI (Computer Assisted Stop Smoking Intervention for the World Wide Web) into a more-portable table and smartphone application (app) that will be available both in English and Spanish
Pre-testing of the app
Trial Design
1Treatment groups
Experimental Treatment
Group I: Prevention (smoking reduction, Quitting Schedule mobile app)Experimental Treatment4 Interventions
AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule.
AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention
2005
N/A
~1800
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,967 Previous Clinical Trials
1,804,802 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,667 Total Patients Enrolled
2 Trials studying Smokers
1,250 Patients Enrolled for Smokers
Paul CinciripiniPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
3,021 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You need to have either an iPhone or an Android smartphone (for Aim 2).You are willing to download and use the Quitting Schedule app as part of the study.Both males and females can participate (for Aim 2).You have smoked at least 100 cigarettes in your lifetime and are currently seeking care at the Tobacco Treatment Program at MD Anderson or Houston area community services.You do not want to take part in the study's second goal.You are currently using nicotine replacement therapy or other medications to help quit smoking, such as Varenicline or Bupropion, outside of the MD Anderson Institution.
Research Study Groups:
This trial has the following groups:- Group 1: Prevention (smoking reduction, Quitting Schedule mobile app)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research experiment presently enrolling participants?
"Per the latest update on clinicaltrials.gov, this medical research is no longer searching for volunteers; originally posted in March 2017 and last edited June 2022. Despite its closure, there are 2392 other trials recruiting participants right now."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger